IQVIA

News

Pharma’s engagement with HCPs evolving, finds new poll

Understanding the needs and behaviour of healthcare professionals is the number one priority for pharma as it interacts with the medical profession in 2024, marking a grad

News

Patient organisations 'a major source of R&D funding'

The pivotal role of patient organisations as a driver for research into new therapies, patient services and access to care has been highlighted by IQVIA, which found that

R&D

Trials and tribulations of drug development: What does it ta...

Rare diseases are a complex and challenging area of medicine, affecting millions of people worldwide.

Sales & Marketing

NHS-life sciences partnership: Learning and recovering from ...

In a recent IQVIA webinar, ‘Partnering with the NHS in a crisis’, representative experts from the life sciences industry and the NHS explored why collaboration between the two is more criti

Oncology

Better balance of cancer treatment efficacy and toxicity

The FDA Oncology Center of Excellence announced its Project Optimus draft guidance in January.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Partnering with NHS in a crisis: The role for industry

There has never been a better opportunity for the pharmaceutical industry for new partnerships